GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Rating of "Hold" from Brokerages

Key Points

• GE HealthCare Technologies has a consensus “Hold” rating from 21 analysts, with 11 holds and 10 buys. The average 12-month price target is $77.73, compared with the stock’s reported price of $73.91.
• Recent analyst actions were mixed: BNP Paribas Exane cut its target to $88, UBS raised its target to $73 while maintaining a neutral rating, and Piper Sandler reiterated a buy recommendation.
• The company exceeded quarterly expectations, reporting adjusted EPS of $1.13 versus a $1.04 consensus and revenue of $5.29 billion, up 5.8% year over year. Institutional investors own 82.06% of the stock, and GE HealthCare pays a quarterly dividend of $0.035.

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) have earned an average rating of "Hold" from the twenty-one research firms that are covering the firm, MarketBeat.com reports. Eleven research analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $77.7273.

A number of research analysts have recently commented on the company. BNP Paribas Exane lowered their price objective on GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of GE HealthCare Technologies in a research report on Wednesday, August 12th. The Goldman Sachs Group reiterated a "neutral" rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. UBS Group lifted their price target on shares of GE HealthCare Technologies from $67.00 to $73.00 and gave the company a "neutral" rating in a research report on Friday, July 31st. Finally, Piper Sandler restated a "buy" rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of hedge funds have recently bought and sold shares of GEHC. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies in the fourth quarter worth about $26,000. NBH Bank bought a new stake in GE HealthCare Technologies during the 2nd quarter valued at approximately $26,000. Godfrey Financial Associates Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Montag A & Associates Inc. grew its holdings in GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company's stock valued at $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC increased its position in GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company's stock worth $28,000 after buying an additional 262 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.4%

Shares of NASDAQ:GEHC opened at $73.91 on Wednesday. The stock has a market capitalization of $33.38 billion, a PE ratio of 16.95, a P/E/G ratio of 2.14 and a beta of 0.69. GE HealthCare Technologies has a 1 year low of $58.75 and a 1 year high of $89.77. The firm has a fifty day moving average price of $67.01 and a 200 day moving average price of $69.43. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the prior year, the business posted $1.06 earnings per share. The business's quarterly revenue was up 5.8% on a year-over-year basis. Analysts expect that GE HealthCare Technologies will post 4.93 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date was Friday, July 24th. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.21%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source